Press Releases

  • July 21, 2022

    Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program

    Loughborough, England – July 21, 2022 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    June 30, 2022

    Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022

    Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    May 23, 2022

    Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

    Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on...

    February 28, 2022

    Nemaura Medical Wins Innovation Awards

    Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    February 14, 2022

    Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update

    Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    January 11, 2022

    Nemaura Medical Appoints Dr Arash Ghadar as Chief Operating Officer

    Loughborough, England – January 10, 2022 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    January 7, 2022

    Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

    Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on...

    December 7, 2021

    Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee

    Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07,...

    November 3, 2021

    Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021

    Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing...

    September 29, 2021

    Nemaura Medical Launches Beta Version of Its Metabolic Health Program

    MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England,...